THANK YOU FOR SUBSCRIBING


Salvatore De Furia, CEO and President
Fuelled by their ambition, Salvatore and Lodari transformed the business, erecting a state-of-the-art production facility spanning 15,000 square-meter. This significant shift led to the rebirth of the company, now known as Pharmintechs Group.

Today, the company has headquarters in London and production facilities all across the UK, making it a powerhouse in the entire region.
Pharmintechs stands tall as the global partner of choice for pharmaceutical, healthcare, wellness, and biotechnology sectors, offering an extensive array of products for medication packaging and administration solutions. Its commitment to innovation, quality, and customer-centric approach has cemented the company’s position as a leader in the industry, carrying forward the entrepreneurial spirit that started generations ago in De Furia’s family.

Offering Products beyond Mere Containment Solutions
Pharmintechs is dedicated to excellence, with all its production plants holding ISO 9001:2015 and ISO 15378:2017 certifications. Adhering strictly to Good Manufacturing Practice (GMP) standards, it oversees around five production sites and a team of 450 professionals.
De Furia says, “Pharmintechs creates cutting-edge drug containment and delivery solutions for pharmaceutical and biotechnology industries.
Partnering with industry leaders, Pharmintechs offers more than just containment solutions. It also provides innovative drug delivery systems, producing over three billion drug containers annually, making the company a significant player in the injectable drug market.
Recognizing the complexity of advanced drug containment, Pharmintechs goes beyond conventional practices. The company strives to innovate, setting new standards in secure medication delivery. Collaborations between its researchers and accredited labs enable it to offer science-based solutions, supporting pharmaceutical companies in achieving excellence.
![]()
Pharmintechs Creates Cutting-Edge Drug Containment And Delivery Solutions For Pharmaceutical And Biotechnology Industries. Our Range Includes Syringes, Cartridges, Vials, And Ampoules Made With Top-Quality Materials Like Type I Borosilicate Glass And Premium Pharmaceutical Polymers
Every passing minute witnesses over 25,000 patients receiving injections stored in Pharmintechs’ primary packaging products, affirming its dedication to prioritizing patient safety and convenience. The overarching goal of the company remains clear: to make medication administration safe, seamless, and, most importantly, humane—acknowledging the inherent value of human health.

Pharmintechs isn’t merely an entity churning out containers; it’s an epitome of dedication, innovation, and a profound commitment to improving lives.
“It’s not just about what we produce; it’s about how we propel the future of pharmaceutical care, ensuring every medication reaches its destination securely, efficiently, and with reliability,” says De Furia.
Enabling Storage and Injection of Various Vaccines and Diluents
Pharmintechs is at the forefront of developing premium pre-fillable glass syringes (PFS), leveraging superior glass tubing and syringe systems expertise. These PFS solutions streamline drug injection preparations, ensuring safety and efficiency for patients and healthcare professionals alike.
The company’s products maintain tight dimensional tolerances for accurate fills, exhibit proven container closure integrity, and support reliable functionality of diverse drug models even at temperatures as low as -70°C.
Facilitating Efficient Packaging
The company’s strategic industrial plan outlines investments exceeding 100 million pounds for upcoming acquisitions and innovative industrial projects in the coming years.

By 2024, operational sales offices in Romania, Brazil, India, Morocco, and Turkey will further solidify Pharmintechs’ global presence. Simultaneously, the construction of a state-of-the-art 50,000 square-meter facility in South Yorkshire will soon be completed. It will specialize in producing the latest generation of syringes capable of safely accommodating cold medicines at temperatures as low as minus 100 degrees Celsius.

Pharmintechs envisions a future propelled by the determination of its founder, aiming to ascend as the top manufacturer in the pharmaceutical packaging sector within the next decade. The company’s team is equipped to support complex drug candidates at any scale, offering specialized expertise in crucial areas such as cold-chain labeling and packaging. Additionally, Pharmintechs provides comprehensive services in clinical label design, utilizing advanced technologies to facilitate efficient packaging for global clinical trial IMPs, accommodating diverse patient needs across different regions without stock commitment based on uncertain forecasts.
Company
Pharmintechs Ltd
Management
Salvatore De Furia, CEO and President
Description
Pharmintechs Ltd is the global partner of choice for the packaging of medicines, devices and solutions for the administration of medicines with the widest range of products for the pharmaceutical, healthcare, wellness and biotechnology sectors.